UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000004278
Receipt number R000004308
Scientific Title A feasibility study of neoadjuvant therapy with cisplatin, pemetrexed, and bevacizumab (Avastin®) in patients with non-squamous non small cell lung cancer (NAVAL study)
Date of disclosure of the study information 2010/10/01
Last modified on 2019/07/29 12:09:52

No. Disposal Last modified on Item of update
1 Insert 2010/09/28 17:21:19
2 Update 2015/10/31 11:30:40 Email
Last name of contact person
Last name of contact person
TEL
Email
Post marketing survey by drug manufacture etc., specified by Japanese law.
3 Update 2017/04/04 16:25:52 Name of primary person or sponsor
Organization
4 Update 2017/04/04 16:26:50 Recruitment status
5 Update 2019/07/29 12:02:40 Recruitment status
Date of IRB
Last follow-up date
6 Update 2019/07/29 12:04:56 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address
Address
TEL

Last name of contact person

Last name of contact person
Zip code
Address
Address
TEL
Organization
Organization
Address
Address
Tel
Email
7 Update 2019/07/29 12:09:52 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures